Zealthy

What it is

Patients complete an online intake and are seen by licensed providers without office visits.

Insurance coordinators try to get brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) covered; compounded semaglutide is offered for out-of-pocket purchase.

Optional coaching with messaging, plus programs for mental health, primary care, birth control, ED, hair loss, skincare, sleep and PrEP.

Prescribes: Brand-name GLP-1s (via insurance) and compounded semaglutide (cash-pay)

What it costs

Insurance: Care team seeks insurance coverage for brand GLP-1s; compounded semaglutide is cash-pay.

Prices change often. Check getzealthy.com before you sign up.

By the numbers

• Trustpilot 3.2/5 from 6,057 reviews (41% 1-star; checked 2026-10-15).7
• BBB: Not Rated; not BBB Accredited; 2,499 complaints in the last 3 years (checked 2026-10-15).8

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Many reviewers describe easy sign-up, quick shipping and satisfaction with weight-loss progress.3
• A large share of reviews report unexpected or continued membership charges, difficulty cancelling, slow refunds and unanswered support messages.3
• Reddit threads about Zealthy are overwhelmingly negative: members describe paying for medication they say they did not fully receive, unexpected charges, and repeated marketing texts after deciding not to buy.121314
• Members frequently point others to the federal government's lawsuit naming Zealthy and its founder when the company comes up.1215
• On Trustpilot (41% one-star), complaints cite recurring membership and medication charges, difficult cancellation, slow refunds and unanswered calls; positive reviews mention easy registration, fast shipping and good results.7

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Jun 2026
   FDA

   FDA sent a warning letter to FitRX, LLC dba AM RX citing false or misleading representations about compounded semaglutide and tirzepatide on getamrx.com and warning that failure to address violations may lead to seizure or injunction.6

2. Apr 2026
   DOJ/FTC

   In the federal case originally filed in 2024 over Cerebral (S.D. Fla.), the DOJ and FTC's amended complaint names Zealthy and founder Kyle Robertson, alleging ROSCA and FTC Act violations including hard-to-cancel subscriptions, undisclosed pricing, review manipulation and misuse of prescribers' NPI numbers; in April 2026 the government asked the court to freeze Zealthy's assets and appoint a receiver. These are allegations; no ruling was found in this check.11

3. Feb 2026
   FDA

   FDA sent a warning letter to FitRX, LLC dba FitRx stating its website implied FitRx was the compounder of its compounded semaglutide and tirzepatide and implied FDA approval.5

4. Sep 2025
   FDA

   FDA sent a warning letter (dba Zealthy) stating website claims presenting compounded semaglutide as having the same active ingredient as Wegovy and Ozempic were false or misleading, misbranding the products under FDCA 502(a) and 502(bb).4